Clinical Trial Update: Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With Tear Film Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing NAAGA to azelastine eye drops in subjects with allergic conjunctivitis and tear film dysfunction has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Dry Eye Disease

Drugs mentioned

• Azelastine Eye Drops (azelastine hydrochloride)
• NAAGA

Snippet

Sponsor: Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona | Conditions: Allergic Conjunctivitis, Dry Eye Disease (DED) | Phase 4 | Status: COMPLETED